CD20 188-196 (HLA-A*02:01)

CD20 188-196 (HLA-A*02:01)
€50.00 *

Prices plus VAT plus shipping costs

Delivery time 3 weeks
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt

Amount in mg:

make your choice

  • EP07888_1
SLFLGILSV is a linear peptidic epitope (epitope ID140742) studied as part of B-lymphocyte antigen... more
Product information "CD20 188-196 (HLA-A*02:01)"
SLFLGILSV is a linear peptidic epitope (epitope ID140742) studied as part of B-lymphocyte antigen CD20 from Homo sapiens (human), tested in T cell assays CD20 188-196 (HLA-A*02:01) SLFLGILSV for stimulation of T-cells. Single peptide (SLFLGILSV) for stimulation of human CD20 (188-196)-specific CD8+ T-cells.SLFLGILSV is a linear peptidic epitope (epitope ID140742) studied as part of B-lymphocyte antigen CD20 from Homo sapiens (human), tested in T cell assays CD20 188-196 (HLA-A*02:01) SLFLGILSV for stimulation of T-cells. Single peptide (SLFLGILSV) for stimulation of human CD20 (188-196)-specific CD8+ T-cells.SLFLGILSV is a linear peptidic epitope (epitope ID140742) studied as part of B-lymphocyte antigen CD20 from Homo sapiens (human), tested in T cell assays CD20 188-196 (HLA-A*02:01) SLFLGILSV for stimulation of T-cells. Single peptide (SLFLGILSV) for stimulation of human CD20 (188-196)-specific CD8+ T-cells.

 
Sequence:SLFLGILSV
Gene:MS4A1
Delivery: 3 weeks
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Protein:B-lymphocyte antigen CD20
Species:Human
Allele:HLA-A*02:01
Application :T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Indication :Cancer
Dokumente - Protokolle - Downloads more
Viewed